Intrathecally administered c-fos antisense oligodeoxynucleotide decreases formalin-induced nociceptive behavior in adult rats
- 1 June 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 329 (1), 17-26
- https://doi.org/10.1016/s0014-2999(97)10093-0
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The application of antisense oligonucleotide technology to the brain: Some pitfallsCellular and Molecular Neurobiology, 1994
- Inhibition of c‐Fos Protein Expression in Rat Spinal Cord by Antisense Oligodeoxynucleotide SuperfusionEuropean Journal of Neuroscience, 1994
- Antisense oligonucleotide strategies in neuropharmacologyTrends in Pharmacological Sciences, 1994
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Activity-dependent neuronal plasticity following tissue injury and inflammationTrends in Neurosciences, 1992
- Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin geneNeuron, 1991
- Behavioural effects of selective ?-, ?-, and ?-opioid agonists in neonatal ratsPsychopharmacology, 1989
- Fos-Like Immunoreactivity Induced by Seizure in Mice Is Specifically Associated With Euchromatin in NeuronsEuropean Journal of Neuroscience, 1989
- κ Opioid receptor-mediated analgesia in the developing ratDevelopmental Brain Research, 1986